- Amgen 2015. In September the company announced it would acquire Dezima Pharma for more than $1.55 billion.[22] The same day the company announced a collobaration withXencor on 6 early stage immuno-oncology and inflammation programmes. As part of the deal Amgen will pay $45 million upfront, with the deal being worth up to another $1.7 billion.[23][